Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant

Go back to Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant
(NASDAQ: COCH) Delayed: 0.71 +0.03 (4.41%)
Previous Close $0.68    52 Week High
Open $0.67    52 Week Low
Day High $0.71    P/E N/A 
Day Low $0.67    EPS
Volume 48,510